Hjem › Leverkreft › California › Los Angeles
Kliniske studier for Leverkreft i Los Angeles, CA
11 studier for Leverkreft søker deltakere på steder i og rundt Los Angeles (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
RekruttererFase 1/2
- START Los Angeles, LLC, Los Angeles
- Keck Hospital of USC, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- og 3 flere
National Liver Cancer Screening Trial
RekruttererFase 4
- University of Southern California, Los Angeles
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
RekruttererFase 1
- USC Norris Comprehensive Cancer Center /ID# 271573, Los Angeles
CREO - Microwave Ablation Feasibility Study
Rekrutterer
- Cedars Sinai, Los Angeles
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RekruttererObservasjonsstudie
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekruttererFase 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
RekruttererFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
RekruttererFase 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruttererFase 1
- Clinical Trial Site, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RekruttererFase 1
- Start Lacn, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Rekrutterer
- Cedars-Sinai Medical Center, Los Angeles
Leverkreft-studier i andre byer
- Houston, TX14 studier
- Cleveland, OH11 studier
- Dallas, TX10 studier
- Boston, MA9 studier
- Chicago, IL8 studier
- St. Louis, MO8 studier
- Durham, NC7 studier
- Philadelphia, PA7 studier
- San Francisco, CA6 studier
- New York City, NY6 studier
- Washington, DC6 studier
- Orange, CA6 studier
Andre studier i Los Angeles
- Ikke-småcellet lungekreft87 studier
- Kreft (alle typer)74 studier
- Brystkreft73 studier
- Prostatakreft61 studier
- Kolorektal kreft59 studier
- Metastatisk kreft57 studier
- Eggstokkreft50 studier
- Lungekreft45 studier
- Plateepitelcancer i hode og hals42 studier
- Pankreaskreft35 studier
- Endometriekreft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.